{"pmid":32417315,"title":"Short-term outcomes in individuals aged 75 or older with severe coronavirus disease (COVID-19): First observations from an Infectious Diseases Unit in Southern Italy.","text":["Short-term outcomes in individuals aged 75 or older with severe coronavirus disease (COVID-19): First observations from an Infectious Diseases Unit in Southern Italy.","J Infect","Bruno, Giuseppe","Perelli, Serena","Fabrizio, Claudia","Buccoliero, Giovanni Battista","32417315"],"journal":"J Infect","authors":["Bruno, Giuseppe","Perelli, Serena","Fabrizio, Claudia","Buccoliero, Giovanni Battista"],"date":"2020-05-18T11:00:00Z","year":2020,"_id":"32417315","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.jinf.2020.05.024","topics":["Diagnosis","Treatment"],"weight":1,"_version_":1667058206799560704,"score":9.490897,"similar":[{"pmid":32492533,"title":"Clinical Features and Short-term Outcomes of Elderly Patients With COVID-19.","text":["Clinical Features and Short-term Outcomes of Elderly Patients With COVID-19.","BACKGROUND: The outbreak of Coronavirus Disease 2019 (COVID-19) has become a global public health emergency. METHODS: 204 elderly patients (>/=60 years old) diagnosed with COVID-19 in Renmin Hospital of Wuhan University from January 31(st) to February 20(th), 2020 were included in this study. Clinical endpoint was in-hospital death. RESULTS: Of the 204 patients, hypertension, diabetes, cardiovascular disease, and chronic obstructive pulmonary disease (COPD) were the most common coexisting conditions. 76 patients died in the hospital. Multivariate analysis showed that dyspnea (hazards ratio (HR) 2.2, 95% confidence interval (CI) 1.414 to 3.517;p < 0.001), older age (HR 1.1, 95% CI 1.070 to 1.123; p < 0.001), neutrophilia (HR 4.4, 95% CI 1.310 to 15.061; p = 0.017) and elevated ultrasensitive cardiac troponin I (HR 3.9, 95% CI 1.471 to 10.433; p = 0.006) were independently associated with death. CONCLUSION: Although so far the overall mortality of COVID-19 is relatively low, the mortality of elderly patients is much higher. Early diagnosis and supportive care are of great importance for the elderly patients of COVID-19.","Int J Infect Dis","Li, Ping","Chen, Lulu","Liu, Zheming","Pan, Jinghui","Zhou, Dingyi","Wang, Hui","Gong, Hongyun","Fu, Zhenmin","Song, Qibin","Min, Qian","Ruan, Shasha","Xu, Tangpeng","Cheng, Fan","Li, Xiangpan","32492533"],"abstract":["BACKGROUND: The outbreak of Coronavirus Disease 2019 (COVID-19) has become a global public health emergency. METHODS: 204 elderly patients (>/=60 years old) diagnosed with COVID-19 in Renmin Hospital of Wuhan University from January 31(st) to February 20(th), 2020 were included in this study. Clinical endpoint was in-hospital death. RESULTS: Of the 204 patients, hypertension, diabetes, cardiovascular disease, and chronic obstructive pulmonary disease (COPD) were the most common coexisting conditions. 76 patients died in the hospital. Multivariate analysis showed that dyspnea (hazards ratio (HR) 2.2, 95% confidence interval (CI) 1.414 to 3.517;p < 0.001), older age (HR 1.1, 95% CI 1.070 to 1.123; p < 0.001), neutrophilia (HR 4.4, 95% CI 1.310 to 15.061; p = 0.017) and elevated ultrasensitive cardiac troponin I (HR 3.9, 95% CI 1.471 to 10.433; p = 0.006) were independently associated with death. CONCLUSION: Although so far the overall mortality of COVID-19 is relatively low, the mortality of elderly patients is much higher. Early diagnosis and supportive care are of great importance for the elderly patients of COVID-19."],"journal":"Int J Infect Dis","authors":["Li, Ping","Chen, Lulu","Liu, Zheming","Pan, Jinghui","Zhou, Dingyi","Wang, Hui","Gong, Hongyun","Fu, Zhenmin","Song, Qibin","Min, Qian","Ruan, Shasha","Xu, Tangpeng","Cheng, Fan","Li, Xiangpan"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32492533","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.ijid.2020.05.107","keywords":["clinical features","coronavirus disease 2019 (covid-19)","short-term outcomes","elderly"],"topics":["Diagnosis"],"weight":1,"_version_":1668623433586442240,"score":57.182068},{"pmid":32312863,"pmcid":"PMC7173674","title":"Short-term Outcomes of Coronavirus Disease 2019 and Risk Factors for Progression.","text":["Short-term Outcomes of Coronavirus Disease 2019 and Risk Factors for Progression.","Eur Respir J","Long, Li","Zeng, Xiansheng","Zhang, Xu","Xiao, Wei","Guo, E","Zhan, Wenzhi","Yang, Xuejiao","Li, Chunyan","Wu, Caiyun","Xu, Tingting","Zhan, Chen","Chen, Yuehan","Jiang, Mei","Zhong, Nanshan","Lai, Kefang","32312863"],"journal":"Eur Respir J","authors":["Long, Li","Zeng, Xiansheng","Zhang, Xu","Xiao, Wei","Guo, E","Zhan, Wenzhi","Yang, Xuejiao","Li, Chunyan","Wu, Caiyun","Xu, Tingting","Zhan, Chen","Chen, Yuehan","Jiang, Mei","Zhong, Nanshan","Lai, Kefang"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32312863","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1183/13993003.00990-2020","topics":["Treatment"],"weight":1,"_version_":1666138493536960512,"score":48.931915},{"pmid":32354634,"pmcid":"PMC7142691","title":"A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia.","text":["A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia.","The outcome of SARS-CoV2 infection in patients who have received a kidney allograft and are being treated with immunosuppression is unclear. We describe 20 kidney transplant recipients (median age 59 years [inter quartile range 51-64 years], median age of transplant 13 years [9-20 years], baseline eGFR 36.5 [23-47.5]) with SARS-CoV2 induced pneumonia. At admission, all had immunosuppression withdrawn and were started on methylprednisolone 16 mg/day, all but one was commenced on antiviral therapy and hydroxychloroquine with doses adjusted for kidney function. At baseline, all patients presented fever but only one complained of difficulty in breathing. Half of patients showed chest radiographic evidence of bilateral infiltrates while the other half showed unilateral changes or no infiltrates. During a median follow-up of seven days, 87% experienced a radiological progression and among those 73% required escalation of oxygen therapy. Six patients developed acute kidney injury with one requiring hemodialysis. Six of 12 patients were treated with tocilizumab, a humanized monoclonal antibody to the IL-6 receptor. Overall, five kidney transplant recipients died after a median period of 15 days [15-19] from symptom onset. These preliminary findings describe a rapid clinical deterioration associated with chest radiographic deterioration and escalating oxygen requirement in renal transplant recipients with SARS-Cov2 pneumonia. Thus, in this limited cohort of long-term kidney transplant patients, SARS-CoV-2 induced pneumonia is characterized by high risk of progression and significant mortality.","Kidney Int","Alberici, Federico","Delbarba, Elisa","Manenti, Chiara","Econimo, Laura","Valerio, Francesca","Pola, Alessandra","Maffei, Camilla","Possenti, Stefano","Zambetti, Nicole","Moscato, Marianna","Venturini, Margherita","Affatato, Stefania","Gaggiotti, Mario","Bossini, Nicola","Scolari, Francesco","32354634"],"abstract":["The outcome of SARS-CoV2 infection in patients who have received a kidney allograft and are being treated with immunosuppression is unclear. We describe 20 kidney transplant recipients (median age 59 years [inter quartile range 51-64 years], median age of transplant 13 years [9-20 years], baseline eGFR 36.5 [23-47.5]) with SARS-CoV2 induced pneumonia. At admission, all had immunosuppression withdrawn and were started on methylprednisolone 16 mg/day, all but one was commenced on antiviral therapy and hydroxychloroquine with doses adjusted for kidney function. At baseline, all patients presented fever but only one complained of difficulty in breathing. Half of patients showed chest radiographic evidence of bilateral infiltrates while the other half showed unilateral changes or no infiltrates. During a median follow-up of seven days, 87% experienced a radiological progression and among those 73% required escalation of oxygen therapy. Six patients developed acute kidney injury with one requiring hemodialysis. Six of 12 patients were treated with tocilizumab, a humanized monoclonal antibody to the IL-6 receptor. Overall, five kidney transplant recipients died after a median period of 15 days [15-19] from symptom onset. These preliminary findings describe a rapid clinical deterioration associated with chest radiographic deterioration and escalating oxygen requirement in renal transplant recipients with SARS-Cov2 pneumonia. Thus, in this limited cohort of long-term kidney transplant patients, SARS-CoV-2 induced pneumonia is characterized by high risk of progression and significant mortality."],"journal":"Kidney Int","authors":["Alberici, Federico","Delbarba, Elisa","Manenti, Chiara","Econimo, Laura","Valerio, Francesca","Pola, Alessandra","Maffei, Camilla","Possenti, Stefano","Zambetti, Nicole","Moscato, Marianna","Venturini, Margherita","Affatato, Stefania","Gaggiotti, Mario","Bossini, Nicola","Scolari, Francesco"],"date":"2020-05-02T11:00:00Z","year":2020,"_id":"32354634","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.kint.2020.04.002","keywords":["acute kidney injury","inflammation","tocilizumab","transplantation"],"e_drugs":["Hydroxychloroquine","tocilizumab","Methylprednisolone"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666138495273402368,"score":48.85077},{"pmid":32448391,"title":"The pulmonary sequalae in discharged patients with COVID-19: a short-term observational study.","text":["The pulmonary sequalae in discharged patients with COVID-19: a short-term observational study.","BACKGROUND: A cluster of patients with coronavirus disease 2019 (COVID-19) pneumonia were discharged from hospitals in Wuhan, China. We aimed to determine the cumulative percentage of complete radiological resolution at each time point, to explore the relevant affecting factors, and to describe the chest CT findings at different time points after hospital discharge. METHODS: Patients with COVID-19 pneumonia confirmed by RT-PCR who were discharged consecutively from the hospital between 5 February 2020 and 10 March 2020 and who underwent serial chest CT scans on schedule were enrolled. The radiological characteristics of all patients were collected and analysed. The total CT score was the sum of non-GGO involvement determined at discharge. Afterwards, all patients underwent chest CT scans during the 1st, 2nd, and 3rd weeks after discharge. Imaging features and distributions were analysed across different time points. RESULTS: A total of 149 patients who completed all CT scans were evaluated; there were 67 (45.0%) men and 82 (55.0%) women, with a median age of 43 years old (IQR 36-56). The cumulative percentage of complete radiological resolution was 8.1% (12 patients), 41.6% (62), 50.3% (75), and 53.0% (79) at discharge and during the 1st, 2nd, and 3rd weeks after discharge, respectively. Patients </=44 years old showed a significantly higher cumulative percentage of complete radiological resolution than patients > 44 years old at the 3-week follow-up. The predominant patterns of abnormalities observed at discharge were ground-glass opacity (GGO) (125 [83.9%]), fibrous stripe (81 [54.4%]), and thickening of the adjacent pleura (33 [22.1%]). The positive count of GGO, fibrous stripe and thickening of the adjacent pleura gradually decreased, while GGO and fibrous stripe showed obvious resolution during the first week and the third week after discharge, respectively. \"Tinted\" sign and bronchovascular bundle distortion as two special features were discovered during the evolution. CONCLUSION: Lung lesions in COVID-19 pneumonia patients can be absorbed completely during short-term follow-up with no sequelae. Two weeks after discharge might be the optimal time point for early radiological estimation.","Respir Res","Liu, Dehan","Zhang, Wanshu","Pan, Feng","Li, Lin","Yang, Lian","Zheng, Dandan","Wang, Jiazheng","Liang, Bo","32448391"],"abstract":["BACKGROUND: A cluster of patients with coronavirus disease 2019 (COVID-19) pneumonia were discharged from hospitals in Wuhan, China. We aimed to determine the cumulative percentage of complete radiological resolution at each time point, to explore the relevant affecting factors, and to describe the chest CT findings at different time points after hospital discharge. METHODS: Patients with COVID-19 pneumonia confirmed by RT-PCR who were discharged consecutively from the hospital between 5 February 2020 and 10 March 2020 and who underwent serial chest CT scans on schedule were enrolled. The radiological characteristics of all patients were collected and analysed. The total CT score was the sum of non-GGO involvement determined at discharge. Afterwards, all patients underwent chest CT scans during the 1st, 2nd, and 3rd weeks after discharge. Imaging features and distributions were analysed across different time points. RESULTS: A total of 149 patients who completed all CT scans were evaluated; there were 67 (45.0%) men and 82 (55.0%) women, with a median age of 43 years old (IQR 36-56). The cumulative percentage of complete radiological resolution was 8.1% (12 patients), 41.6% (62), 50.3% (75), and 53.0% (79) at discharge and during the 1st, 2nd, and 3rd weeks after discharge, respectively. Patients </=44 years old showed a significantly higher cumulative percentage of complete radiological resolution than patients > 44 years old at the 3-week follow-up. The predominant patterns of abnormalities observed at discharge were ground-glass opacity (GGO) (125 [83.9%]), fibrous stripe (81 [54.4%]), and thickening of the adjacent pleura (33 [22.1%]). The positive count of GGO, fibrous stripe and thickening of the adjacent pleura gradually decreased, while GGO and fibrous stripe showed obvious resolution during the first week and the third week after discharge, respectively. \"Tinted\" sign and bronchovascular bundle distortion as two special features were discovered during the evolution. CONCLUSION: Lung lesions in COVID-19 pneumonia patients can be absorbed completely during short-term follow-up with no sequelae. Two weeks after discharge might be the optimal time point for early radiological estimation."],"journal":"Respir Res","authors":["Liu, Dehan","Zhang, Wanshu","Pan, Feng","Li, Lin","Yang, Lian","Zheng, Dandan","Wang, Jiazheng","Liang, Bo"],"date":"2020-05-26T11:00:00Z","year":2020,"_id":"32448391","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1186/s12931-020-01385-1","keywords":["covid-19","ct","discharge","fibrous stripe","follow-up","ggo","sequalae"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1667785214008492032,"score":47.95191},{"pmid":32420710,"title":"Clinical characteristics and short-term outcomes of coronavirus disease 2019: retrospective, single-center experience of designated hospital in Poland.","text":["Clinical characteristics and short-term outcomes of coronavirus disease 2019: retrospective, single-center experience of designated hospital in Poland.","INTRODUCTION: Since the first reported case of coronavirus disease 19 (COVID-19) in Poland, the worldwide pandemic has spread throughout the country, leading to many hospital admissions. There has been urgent need to determine clinical characteristics of Polish patients with laboratory-confirmed SARS-CoV-2 infection in the clinical setting. OBJECTIVES: The aim of this retrospective study was to outline characteristics and short-term outcomes of SARS-CoV-2-positive patients. PATIENTS AND METHODS: We retrospectively characterized 169 consecutive patients with laboratory confirmed COVID-19, with regard to their: clinical manifestations, radiological findings, treatment, complications and outcomes. RESULTS: Of the 169 patients, more than half was aged 65 (n=88, 52,1%) or above, 51,5% were male and 78,3% had comorbidities. Majority of patients (n=106, 62.7%) were transferred from outbreak locations in medical facilities. The most common symptoms on admission were fever (42%), shortness of breath (35%) and fatigue (33%). 27 (15.4%) of patients required intensive care unit admission. Overall mortality was 26.3% (n=46) and was significantly higher in patients transferred from other facilities (38 out of 106, 35.8%), than in patients admitted directly to the hospital (8 out of 63, 12.69%, p<0.001). 17 out of 29 patients admitted to ICU died (mortality = 58,6%), including 30 out of 41 patients with ARDS (73.2% mortality rate in ARDS patients). Conclusion: Polish COVID-19 patients have the similar characteristics and risk factors for adverse outcomes as already observed in countries in which outbreaks occurred earlier. Significantly higher mortality in patients transferred from other centers warrants special attention and transfer policy should be verified.","Pol Arch Intern Med","Nowak, Blazej","Szymanski, Piotr","Pankowski, Igor","Szarowska, Agnieszka","Zycinska, Katarzyna","Rogowski, Wojciech","Gil, Robert","Furmanek, Mariusz","Tatur, Jacek","Zaczynski, Artur","Krol, Zbigniew","Wierzba, Waldemar","32420710"],"abstract":["INTRODUCTION: Since the first reported case of coronavirus disease 19 (COVID-19) in Poland, the worldwide pandemic has spread throughout the country, leading to many hospital admissions. There has been urgent need to determine clinical characteristics of Polish patients with laboratory-confirmed SARS-CoV-2 infection in the clinical setting. OBJECTIVES: The aim of this retrospective study was to outline characteristics and short-term outcomes of SARS-CoV-2-positive patients. PATIENTS AND METHODS: We retrospectively characterized 169 consecutive patients with laboratory confirmed COVID-19, with regard to their: clinical manifestations, radiological findings, treatment, complications and outcomes. RESULTS: Of the 169 patients, more than half was aged 65 (n=88, 52,1%) or above, 51,5% were male and 78,3% had comorbidities. Majority of patients (n=106, 62.7%) were transferred from outbreak locations in medical facilities. The most common symptoms on admission were fever (42%), shortness of breath (35%) and fatigue (33%). 27 (15.4%) of patients required intensive care unit admission. Overall mortality was 26.3% (n=46) and was significantly higher in patients transferred from other facilities (38 out of 106, 35.8%), than in patients admitted directly to the hospital (8 out of 63, 12.69%, p<0.001). 17 out of 29 patients admitted to ICU died (mortality = 58,6%), including 30 out of 41 patients with ARDS (73.2% mortality rate in ARDS patients). Conclusion: Polish COVID-19 patients have the similar characteristics and risk factors for adverse outcomes as already observed in countries in which outbreaks occurred earlier. Significantly higher mortality in patients transferred from other centers warrants special attention and transfer policy should be verified."],"journal":"Pol Arch Intern Med","authors":["Nowak, Blazej","Szymanski, Piotr","Pankowski, Igor","Szarowska, Agnieszka","Zycinska, Katarzyna","Rogowski, Wojciech","Gil, Robert","Furmanek, Mariusz","Tatur, Jacek","Zaczynski, Artur","Krol, Zbigniew","Wierzba, Waldemar"],"date":"2020-05-19T11:00:00Z","year":2020,"_id":"32420710","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.20452/pamw.15361","locations":["Poland","Polish","Polish","Poland"],"countries":["Poland"],"countries_codes":["POL|Poland"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1667254896733192193,"score":47.526436}]}